Try it
Pharmacology · Fibrinolytics: streptokinase
Sample itemA patient previously treated with streptokinase has another ST-elevation myocardial infarction six months later. Why is streptokinase generally avoided now?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Neutralising antibodies may reduce efficacy and increase allergic reactions
Streptokinase is antigenic because it is derived from streptococci. Prior exposure can produce antibodies, making repeat use less effective and more likely to cause hypersensitivity.
Option by option
A. It cannot activate plasminogen
It forms a complex that activates plasminogen.
B. It permanently inhibits platelet COX-1
Aspirin, not streptokinase, irreversibly inhibits platelet COX-1.
C. It causes vitamin K deficiency
It does not interfere with vitamin K metabolism.
D. Neutralising antibodies may reduce efficacy and increase allergic reactions (correct)
Correct. Antigenicity is the key limitation of repeat streptokinase use.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?